We are live on ! Find out more
BIO.B icon

Bio-Rad Laboratories Class B
BIO.B

5 hedge funds and large institutions have $518K invested in Bio-Rad Laboratories Class B in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.02% less ownership

Funds ownership: 0.07%0.04% (-0.02%)

38% less funds holding

Funds holding: 85 (-3)

52% less capital invested

Capital invested by funds: $1.08M → $518K (-$559K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
-3
Holders Change %
-37.5%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CL
1
CSS LLC
Illinois
$266K -$79.9K -249 -19%
Morgan Stanley
2
Morgan Stanley
New York
$172K
Wells Fargo
3
Wells Fargo
California
$41.1K
WT
4
Whittier Trust
California
$38.7K
UBS Group
5
UBS Group
Switzerland
$242
Focus Partners Wealth
6
Focus Partners Wealth
Massachusetts
-$245K -760 Closed
IUHSA
7
Itau Unibanco Holding S.A.
Brazil
-$41.7K -127 Closed
Jones Financial Companies
8
Jones Financial Companies
Missouri
-$12.5K -38 Closed

BIO.B Hedge Fund Activity: Q1 2025 in Review

5 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q1 2025, worth a combined $518K — down 52% from $1.08M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BIO.B and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Focus Partners Wealth, exiting entirely with an estimated $245K sold.

  • 5 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q1 2025, down from 8 in Q4 2024.
  • Funds reported $518K of Bio-Rad Laboratories Class B stock for Q1 2025, down 52% quarter-over-quarter.
  • 0 funds opened new Bio-Rad Laboratories Class B positions in Q1 2025 and 3 closed out, a net change of -3 holders.
  • The largest Bio-Rad Laboratories Class B seller in Q1 2025 was Focus Partners Wealth, an estimated $245K sold.

Based on aggregated 13F filings for Q1 2025.